Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions.
Structural changes accompanying the binding of ligands to the cloned human delta-opioid receptor immobilized in a solid-supported lipid bilayer have been investigated using coupled plasmon-waveguide resonance spectroscopy. This highly sensitive technique directly monitors mass density, conformation, and molecular orientation changes occurring in anisotropic thin films and allows direct determination of binding constants. Although both agonist binding and antagonist binding to the receptor cause increases in molecular ordering within the proteolipid membrane, only agonist binding induces an increase in thickness and molecular packing density of the membrane. This is a consequence of mass movements perpendicular to the plane of the bilayer occurring within the lipid and receptor components. These results are consistent with models of receptor function that involve changes in the orientation of transmembrane helices.
Salamon
Z
Z
Department of Biochemistry, University of Arizona, Tucson, Arizona 85721, USA.
Cowell
S
S
Varga
E
E
Yamamura
H I
HI
Hruby
V J
VJ
Tollin
G
G
D055592:Biophysical Phenomena; D001703:Biophysics; D020881:Enkephalin, D-Penicillamine (2,5)- / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008024:Ligands; D008051:Lipid Bilayers; D008958:Models, Molecular; D009271:Naltrexone / Q000031:analogs & derivatives / Q000378:metabolism; D011487:Protein Conformation; D017465:Receptors, Opioid, delta / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D011994:Recombinant Proteins / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D020349:Surface Plasmon Resonance
D008024:Ligands; D008051:Lipid Bilayers; D017465:Receptors, Opioid, delta; D011994:Recombinant Proteins; D009271:Naltrexone; D020881:Enkephalin, D-Penicillamine (2,5)-; C055382:naltrindole